187 related articles for article (PubMed ID: 34045900)
1. Absolute Circulating Leukemic Cells as a Risk Factor for Early Bleeding Events in Patients with Non-High-Risk Acute Promyelocytic Leukemia.
Pei Y; Shi M; Song J; Niu X; Wei S; Dou L; Xiao M; Li D; Xu F; Bai Y; Sun K
Cancer Manag Res; 2021; 13():4135-4146. PubMed ID: 34045900
[TBL] [Abstract][Full Text] [Related]
2. Value of the FDP/FIB ratio in predicting early severe bleeding events in patients with newly diagnosed acute promyelocytic leukemia.
Li S; Gao Y; Li F; Zheng Y; Su Y
Ann Hematol; 2023 Apr; 102(4):787-794. PubMed ID: 36750485
[TBL] [Abstract][Full Text] [Related]
3. [Correlation between D-Dimer/Fibrinogen Ratio and Bleeding in Patients with Newly Diagnosed Acute Promyelocytic Leukemia].
Li SS; Yang XW; Zheng Y; Gao YJ; Su YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1340-1344. PubMed ID: 37846682
[TBL] [Abstract][Full Text] [Related]
4. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
Chang H; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Lin TL; Hung YS; Tang TC
Eur J Haematol; 2012 Apr; 88(4):321-8. PubMed ID: 22221178
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors for differentiating thrombohemorrhagic disorders in high-risk acute promyelocytic leukemia.
Xiao M; Zhou P; Liu Y; Wei S; Li D; Li W; Niu X; Niu J; Zhang Y; Cao W; Liu B; Wang X; Bai Y; Sun K
Thromb Res; 2022 Feb; 210():33-41. PubMed ID: 34998209
[TBL] [Abstract][Full Text] [Related]
6. Investigation of fibrinogen in early bleeding of patients with newly diagnosed acute promyelocytic leukemia.
Chu T; Wang H; Lv X; Qi J; Tang Y; Fan Y; Qiu H; Tang X; Fu C; Ruan C; Han Y; Wu DP
Platelets; 2021 Jul; 32(5):677-683. PubMed ID: 32799612
[TBL] [Abstract][Full Text] [Related]
7. The level of peripheral blood circulating CD34+ cells is higher in acute promyelocytic leukemia patients with adverse prognostic factors.
Zeng H; Yin LD; Li P; Yuan YH; Guan CY; Xie T; Zhang QG
Hematology; 2016 Oct; 21(9):513-9. PubMed ID: 27077772
[TBL] [Abstract][Full Text] [Related]
8. Increased promyelocytic-derived microparticles: a novel potential factor for coagulopathy in acute promyelocytic leukemia.
Ma G; Liu F; Lv L; Gao Y; Su Y
Ann Hematol; 2013 May; 92(5):645-52. PubMed ID: 23344645
[TBL] [Abstract][Full Text] [Related]
9. Effectivity of a modified Sanz risk model for early death prediction in patients with newly diagnosed acute promyelocytic leukemia.
Lou Y; Ma Y; Sun J; Suo S; Tong H; Qian W; Mai W; Meng H; Jin J
Ann Hematol; 2017 Nov; 96(11):1793-1800. PubMed ID: 28823055
[TBL] [Abstract][Full Text] [Related]
10. Low platelet count is potentially the most important contributor to severe bleeding in patients newly diagnosed with acute promyelocytic leukemia.
Song YH; Peng P; Qiao C; Zhang R; Li JY; Lu H
Onco Targets Ther; 2017; 10():4917-4924. PubMed ID: 29062237
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of early death factors and prognosis of acute promyelocytic leukemia].
Wu YX; Wu DP; Chen SN; Qiu HY; Han Y; Li CX; Ma X; Sun AN; Tang XW; Hu XH
Zhonghua Xue Ye Xue Za Zhi; 2020 Dec; 41(12):1025-1030. PubMed ID: 33445851
[No Abstract] [Full Text] [Related]
12. [Effects of Cytokines on Early Death in Patients with Newly Diagnosed Acute Promyelocytic Leukemia].
Zhao SX; Ge YY; Li ZZ; He HP; Shen CM; Shi KQ; Yang TH; DU YY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1315-1321. PubMed ID: 37846678
[TBL] [Abstract][Full Text] [Related]
13. Gene mutations in acute promyelocytic leukemia early death in patients treated with arsenic trioxide alone.
Chen X; Fan S; Zhao Y; Zhou J
Clin Transl Oncol; 2021 Oct; 23(10):2171-2180. PubMed ID: 33942222
[TBL] [Abstract][Full Text] [Related]
14. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis and treatment of thrombohemorrhagic diathesis in acute promyelocytic leukemia.
Falanga A; Russo L; Tartari CJ
Mediterr J Hematol Infect Dis; 2011; 3(1):e2011068. PubMed ID: 22220265
[TBL] [Abstract][Full Text] [Related]
16. Predictors of early hemorrhage in acute promyelocytic leukemia.
Naymagon L; Moshier E; Tremblay D; Mascarenhas J
Leuk Lymphoma; 2019 Oct; 60(10):2394-2403. PubMed ID: 30849255
[TBL] [Abstract][Full Text] [Related]
17. CD44-fibrinogen binding promotes bleeding in acute promyelocytic leukemia by in situ fibrin(ogen) deposition.
Wang C; Wang Y; Zuo N; Fang S; Shi J
Blood Adv; 2022 Aug; 6(15):4617-4633. PubMed ID: 35511736
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of acute promyelocytic leukemia manifesting as early death.
He B; Hu S; Qiu G; Gu W
Mol Clin Oncol; 2013 Sep; 1(5):908-910. PubMed ID: 24649269
[TBL] [Abstract][Full Text] [Related]
19. Using Antigen Expression of Leukemic Cells for a Fast Screening of Acute Promyelocytic Leukemia by Flow Cytometry.
Ceni-Silva V; Pagnano K; Duarte G; Pellegrini M; Duarte B; Metze K; Lorand-Metze I
Diagnostics (Basel); 2021 Oct; 11(11):. PubMed ID: 34829335
[TBL] [Abstract][Full Text] [Related]
20. Types, Clinical Features, and Survival Outcomes of Patients with Acute Myeloid Leukemia in Thailand: A 3-Year Prospective Multicenter Study from the Thai Acute Leukemia Study Group (TALSG).
Wanitpongpun C; Utchariyaprasit E; Owattanapanich W; Tantiworawit A; Rattarittamrong E; Niparuck P; Puavilai T; Julamanee J; Saelue P; Chanswangphuwana C; Polprasert C; Nakhakes C; Limvorapitak W; Kanitsap N; Prayongratana K; Sriswasdi C
Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):e635-e643. PubMed ID: 33926829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
